This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Oncology  • Skin Cancer  • Dermatology  • Melanoma  • Alert me on articles by topic

Edited by K. Nouri
709 pp, $159
New York, NY, McGraw Hill, 2008
ISBN-13: 978-0-0714-7256-2

JAMA. 2008;299(16):1961.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Cutaneous malignancies are an increasing problem in the practice of medicine, whether due to patient longevity, increased solar exposure, or undefined factors such as metal exposure or immunologic phenomena. Several important facts remain about the 3 major types of skin cancer (basal cell carcinoma, squamous cell carcinoma, and melanoma): incidence is increasing among white persons around the globe (>1 million new nonmelanoma skin cancers annually in the United States and 2.75 million annually worldwide); mortality is decreasing for patients with basal cell carcinoma and squamous cell carcinoma due to earlier intervention and more appropriate therapy; and incidence of deaths due to melanoma are increasing, outweighing the growth of the number of deaths due to other cancers.

A cause and effect for skin cancers has been known since the seminal work of Sir Percival Pott (1714-1788; St Bartholomew's Hospital, London) in 1775, when he recognized the relationship between tar and scrotal . . . [Full Text of this Article]

Lawrence Charles Parish, MD, Reviewer
Dermatology and Cutaneous Biology
Jefferson Center for International Dermatology
Jefferson Medical College of Thomas Jefferson University
Philadelphia, Pennsylvania
larryderm@yahoo.com